Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

V Gounant1, S Brosseau1,2, G Soussi1

  • 1Université de Paris, Service d'Oncologie thoracique-CIC INSERM 1425, Institut Universitaire du Cancer Paris-Nord, Hôpital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris (AP-HP) 46 rue Henri Huchard, 75018 Paris, Paris, France.

Revue Des Maladies Respiratoires Actualites
|October 18, 2021
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-center retrospective cohort study of lung cancer associated with interstitial lung disease: Prognostic factors and molecular profile.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Four-Year Outcomes of First-Line Nivolumab Plus Ipilimumab for 6 Months Versus Continuation in Patients With Advanced NSCLC: Results of the Randomized IFCT-1701 "DICIPLE" Phase III Trial.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

[Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)].

Revue des maladies respiratoires·2025
Same author

Real-world effectiveness and tolerability of sotorasib in patients with KRAS G12C-mutated metastatic non-small cell lung cancer: The IFCT-2102 Lung KG12Ci study.

European journal of cancer (Oxford, England : 1990)·2025
Same author

[The role of the pulmonologist in the therapeutic strategy for stage I bronchopulmonary cancers?]

Revue des maladies respiratoires·2024
Same author

YAP/TEAD involvement in resistance to paclitaxel chemotherapy in lung cancer.

Molecular and cellular biochemistry·2024
Same journal

Revue des maladies respiratoires actualites·2022
Same journal

Revue des maladies respiratoires actualites·2022
Same journal

Revue des maladies respiratoires actualites·2022
Same journal

Revue des maladies respiratoires actualites·2022
Same journal

[Highlights in Respiratory Medicine in 2021].

Revue des maladies respiratoires actualites·2022
Same journal

Revue des maladies respiratoires actualites·2022
See all related articles

Cancer patients face higher COVID-19 risks and mortality. Lung and hematological cancers pose the greatest threats, while immune checkpoint inhibitors may not worsen outcomes. Vaccination requires careful timing, especially post-chemotherapy.

Area of Science:

  • Oncology
  • Infectious Diseases
  • Public Health
Keywords:
COVID-19ChemotherapyLung cancerVaccinemRNA

Related Experiment Videos